Folks, it looks like some of our US regulations and guidance documents have been flagged for update by FDA….including everyone’s favorite, 21 CFR part 11 (source Cerulean’s email newsletter). I don’t anticipate major changes, just clarification on their intent. Everyone enjoy your Friday.
New Guidance Agenda for 2009 Released by FDA
Readers of our 2009 forecast will find many items on the list familiar:
· Adaptive Clinical Trial Design
TJK
